膀胱腺癌的诊断和治疗(附29例报告)  

Management of adenocarcinoma of urinary bladder(reports of 29 cases)

作　　者：牛海涛[1] 邱志磊[1] 杨惠祥[1] 张一兵[1] 李涛[1] 王一[1] 孙光[1] 

机构地区：[1]天津医科大学第二医院泌尿外科天津市泌尿外科研究所,天津300211

出　　处：《现代泌尿外科杂志》2007年第1期45-47,共3页Journal of Modern Urology

摘　　要：目的提高膀胱腺癌的诊断与治疗水平。方法29例中原发性膀胱腺癌18例,其中行全膀胱切除、尿流改道11例,膀胱部分切除7例;脐尿管腺癌9例,6例行扩大膀胱部分切除术,3例行全膀胱切除、尿流改道;印戒细胞癌2例,行全膀胱切除、尿流改道术。结果4例患者失访,25例患者随访时间为5个月-10年。生存1年者17例(64%),生存2年15例(60%),生存5年5例(20%),生存时间超过5年者均为早期患者。结论早期诊断、鉴别原发性膀胱腺癌与脐尿管腺癌、选择合适的手术方式是膀胱腺癌治疗的关键。Objective To improve the diagnosis accuracy and the treatment of urinary bladder adenocarcinoma. Methods Of the 29 cases of urinary bladder adenocarcinoma, there were 18 cases of primary bladder adenocarcinoma, among which 11 had underwent radical cystectomy and urinary diversion, while the others underwent partial cystectomy. Of the 9 cases of urachal adenocarcinoma, 6 received extended partial bladder resection, 3 underwent radical cystectomy and urinary diversion. 2 cases of signet-ring cell carcinoma received radical cystectomy and urinary diversion. Results During the whole follow-up, 4 patients were lost, 25 were in control, follow-up times ranging from 5 months to 120 months. The 1 year survival rate was 64%（17 cases）, the 2 year survival rate 60% （15 cases） and the 5 year survival rate 20% （5 cases）. All the patients whose survival time exceeded 5 years were in the early stage. Conclusion The key points to the treatment of adenocarcinoma of urinary bladder are early diagnosis, differentiation of primary adenocarcinoma and urachal adenocarcinoma, the most suitable operation method.

关 键 词：膀胱肿瘤 腺癌 治疗学 

分 类 号：R694.54[医药卫生—泌尿科学]